Beta Bionics, Inc. (BBNX) stock
BBNXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/306% above fair value
$16.42−0.09 (-0.55%)
Close on Nov 13, 2026Market cap $892.71MP/E –Yield –
Beta Bionics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Beta Bionics's profit margin for the twelve months ending Sep 30, 2026 was -65.3%. For fiscal 2025 it was -73.0%, against -84.1% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -73.0% | +11.1 |
| FY2024 | Dec 31, 2024 | -84.1% | +283.6 |
| FY2023 | Dec 31, 2023 | -367.6% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -68.6% | −16.5 |
| Q2 FY2026 | Jun 30, 2026 | -73.1% | −0.5 |
| Q1 FY2026 | Mar 31, 2026 | -79.3% | +83.2 |
| Q4 FY2025 | Dec 31, 2025 | -41.9% | +46.7 |
| Q3 FY2025 | Sep 30, 2025 | -52.1% | +6.1 |
| Q2 FY2025 | Jun 30, 2025 | -72.6% | +23.5 |
| Q1 FY2025 | Mar 31, 2025 | -162.5% | −66.2 |
| Q4 FY2024 | Dec 31, 2024 | -88.6% | – |
| Q3 FY2024 | Sep 30, 2024 | -58.3% | – |
| Q2 FY2024 | Jun 30, 2024 | -96.1% | – |
| Q1 FY2024 | Mar 31, 2024 | -96.3% | – |
See a number that looks wrong?